+

WO2018127921A1 - Appareil et procédé pour le rajeunissement de la peau - Google Patents

Appareil et procédé pour le rajeunissement de la peau Download PDF

Info

Publication number
WO2018127921A1
WO2018127921A1 PCT/IL2018/050019 IL2018050019W WO2018127921A1 WO 2018127921 A1 WO2018127921 A1 WO 2018127921A1 IL 2018050019 W IL2018050019 W IL 2018050019W WO 2018127921 A1 WO2018127921 A1 WO 2018127921A1
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
oral mucosa
electrode assembly
tissue
formulation
Prior art date
Application number
PCT/IL2018/050019
Other languages
English (en)
Inventor
Genady Nahshon
Lion Flyash
Original Assignee
Brighttonix Medical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brighttonix Medical Ltd. filed Critical Brighttonix Medical Ltd.
Publication of WO2018127921A1 publication Critical patent/WO2018127921A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0472—Structure-related aspects
    • A61N1/0476—Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0548—Oral electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/06—Electrodes for high-frequency therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/328—Applying electric currents by contact electrodes alternating or intermittent currents for improving the appearance of the skin, e.g. facial toning or wrinkle treatment

Definitions

  • the present invention is generally in the field of aesthetic and cosmetic devices and methods, and relates specifically to tissue rejuvenation, and more specifically to facial skin rejuvenation.
  • Facial rejuvenation is a cosmetic treatment aimed at restoring a youthful appearance to the human face. Facial rejuvenation can be achieved through either invasive and/or non-invasive procedures.
  • Invasive procedures can restore facial symmetry through surgical interventions, such as facial restructuring and skin alterations.
  • the surgical procedures include, for example, a brow lift (forehead lift), eye lift (blepharoplasty), facelift (rhytidectomy), chin lift and neck lift.
  • Non-invasive procedures can target and treat specific or localized facial structures, such as wrinkles, skin laxity, hyperpigmentation and scars.
  • the non-invasive treatments include, for example, chemical peels, neuromodulator (e.g., botulinum toxin
  • WO04011086 describes a method for rejuvenating face neck and body skin.
  • the method includes simultaneously exposing a skin to the action of electric current and electromagnetic radiation (red laser and/or infrared laser radiation) .
  • the method makes it possible to use ozone for photobiological activation of tissue and cell metabolism.
  • WO 16066051 describes a 3D integrated facial beauty instrument, comprising a mask and a circuit board provided in the mask, wherein several RF metal bump means electrically connected to the circuit board are provided in the mask for performing radio frequency nursing with a deep transparent effect on the face, and can solve facial problems such as skin rejuvenation, and can be used against wrinkles, for acne treatment, whitening, and removing blemishes at the same time.
  • WO2014150090 describes a device directed to treatment of a migraine headache or other nervous system malady such as seizures and epilepsy by applying electrical stimulation to a subject's oral mucosa.
  • Noninvasive electrodes may be placed against the subject's oral mucosa tissue by inserting a mouthpiece comprising the electrodes into the subject's mouth.
  • One or more electrical pulses may be applied to the electrodes to stimulate the subjects cranial nerves and thereby treat the malady.
  • the present invention provides novel apparatus and method for non-invasively and safely rejuvenating and tightening facial skin with remarkable and effective results.
  • the invention enables easy, safe and accessible facial rejuvenation for home as well as professional use.
  • the technique of the invention utilizes application of Radio-Frequency (RF) energy/current to internal side (from intraoral cavity) of the face, inter alia to oral mucosa.
  • RF Radio-Frequency
  • current techniques apply RF energy to the outer facial skin tissue which is occasionally accompanied with side effects, such as burns and varied, non- homogeneous, skin look and color.
  • the application of the RF current/energy is aimed at heating the internal side of the facial tissue, i.e. the deep layers of the skin tissue, in order to stimulate a healing process that causes tightening of the facial outer skin.
  • the heating of surface and deep intraoral tissue according to a predetermined temperature profile, caused by a defined RF energy application, induces tissue remodeling and stimulates sub- dermal collagen and and/or elastin production which in turn reduces the appearance of fine lines and loose skin on the outer facial tissue.
  • the skin rejuvenation can be further enhanced by simultaneous application of the RF energy together with a specific formulation to the internal facial tissue.
  • the formulation can be selected from a group of formulations known for their collagen building effects and contribution to the tightening of the skin.
  • the formulation is Hyaluronic Acid.
  • the present invention provides flexible, selective and controllable application of the rejuvenation procedure, i.e. control over precise location of the treatment and/or control over the treatment parameter(s)/condition(s) of the specific facial tissue portion.
  • the present invention provides a flexible tissue tightening device which enables selective application of a treatment mode having defined conditions/parameters to a specific facial tissue site. For example, applying a single mode treatment session of defined parameters (e.g., temperature, duration) to the facial tissue.
  • defined parameters e.g., temperature, duration
  • different facial regions such as cheeks, lips and chin, can be subjected to different profiles of the applied RF energy, e.g. by differentiating the magnitude and/or duration and/or time pattern of the applied RF energy to specific simultaneously treated facial regions.
  • the present invention provides a flexible tissue tightening device which enables selective application of a plurality (at least two) of treatment modes of different conditions/parameters to different facial tissue sites at the same time or during the same treatment session, thus providing fast and effective treatment.
  • the application of the RF energy and the formulation, when used, is carried out by a dedicated mouth-piece applicator configured to be positioned in the oral cavity and contact the internal side, the oral mucosa, of the facial tissue.
  • the applicator carries thereon electrode(s) and a chamber for receiving the formulation, such that the formulation is located between the electrode(s) and the intraoral tissue.
  • the RF energy can be applied in mono or bi-polar mode.
  • the electrode(s) is/are located on the applicator, either fully or partially exposed on the outer side thereof.
  • two electrodes working in bi-polar mode are located with a predetermined distance one above the other on the mouth-piece applicator, such that a current flows therebetween through the facial tissue and the formulation, if used.
  • RF energy should be interpreted broadly covering at least “electric field”, “magnetic field”, or “electromagnetic field” utilizing both electric and magnetic energies. Such RF energy may be applied by an alternating current (AC) signal.
  • AC alternating current
  • the application of RF energy, during a treatment session can have certain time and frequency pattern (i.e. being a function of time and/or frequency), the application can be continuous or pulsatile.
  • alternating field refers to a field that reverses its polarity at regularly or irregularly recurring intervals of time, and which thus has alternatively positive and negative values.
  • the shape / profile of the alternating field/current could be of a sinusoidal, rectangular, triangular, saw tooth or any other shape.
  • an apparatus for facial skin tissue rejuvenation comprising: a mouth-piece applicator configured to be inserted into the mouth for applying RF energy to at least a portion of oral mucosa located opposite a facial skin tissue portion undergoing rejuvenation treatment, the applicator comprising: a housing comprising a treatment surface configured to be positioned in the vicinity of the portion of oral mucosa; an electrode assembly mounted on the treatment surface such that the electrode assembly faces the portion of the oral mucosa, the electrode assembly being configured to deliver RF current of a predetermined profile to the portion of oral mucosa, thereby heating deep tissue layers under the portion of oral mucosa to a predetermined temperature profile; and a power source and control unit being in signal communication with said electrode assembly and configured to generate at least one activation signal having a predetermined time-frequency profile to controllably operate the electrode assembly to create said predetermined profile of RF current and generate said predetermined temperature profile, thereby stimulating collagen formation and tightening of
  • the housing may further comprise a chamber aligned with said electrode assembly and configured to receive therein a formulation, such that the formulation is located in the vicinity of both said electrode assembly and said portion of oral mucosa.
  • said housing has a U-like shape having U arms configured to surround the subject's teeth and push against right and left sides of the oral mucosa.
  • said housing has a dental tray-like shape being configured to be placed on the subject's arcade, said treatment surface being on outer side of the dental tray such that the treatment surface faces the oral mucosa.
  • the electrode assembly may comprise at least one electrode aligned with said portion of oral mucosa, said at least one electrode being operated in a monopolar activation mode.
  • the electrode assembly comprises at least one pair of electrodes located one above the other with a predetermined distance therebetween, said at least one pair of electrodes being operated in a bi-polar activation mode.
  • the electrode assembly comprises an array of spaced-apart electrodes configured and operable to be individually or collectively operated in mono- and/or bi-polar activation mode to deliver a plurality of RF currents to a respective plurality of oral mucosa tissue portions.
  • the power source and control unit may comprise at least one of the following: a power inlet for connecting to a DC outlet, a power inlet for connecting to an AC outlet, a rechargeable battery, a single-use battery, a mobile phone, a tablet computer, a laptop computer, and a DC to AC converter.
  • the power source and control unit further comprises a memory unit, the memory unit being configured to store at least one of the following: i) at least one treatment parameter, and ii) at least one physical parameter.
  • the power source and control unit may be configured to control said at least one treatment parameter or said at least one physical parameter.
  • the treatment parameter may comprise at least one of the following: treatment time, magnitude of the RF current, type of AC waveform, AC frequency, temperature of the oral cavity, temperature of the deep tissue layers, magnitude of the voltage and duty cycle of the RF current.
  • the physical parameter may be related to at least one of the following: the formulation, the applicator, at least one electrode, the oral mucosa portion or a tissue in the vicinity of the oral mucosa portion, tissue reflectivity, tissue impedance, applicator temperature, electrode assembly temperature, formulation temperature, formulation impedance, current, and voltage.
  • the apparatus may comprise at least one sensor comprising at least one of the following: a thermistor, an optical sensor, an ammeter, an impedance meter, and a voltage meter.
  • the control unit may be configured to store at least one measurement by said at least one sensor.
  • the apparatus may comprise feedback control for said at least one treatment parameter, wherein said feedback control operates in method comprising steps of: (i) measuring a physical parameter and (ii) altering at least one said treatment parameter based on said measurement of said physical parameter.
  • a method of facial tissue rejuvenation treatment comprises applying RF current of a predetermined profile to at least a portion of oral mucosa located opposite a facial skin tissue portion undergoing the facial tissue rejuvenation treatment; and maintaining said application of the RF current until a predetermined temperature profile is achieved in deep tissue layers under said portion of oral mucosa; thereby stimulating collagen formation in said deep tissue layers and tightening of said facial skin tissue portion.
  • the method may further comprise simultaneously applying to said portion of oral mucosa, with said RF current, a formulation known for its collagen building stimulating effect.
  • the formulation may include Hyaluronic Acid.
  • Fig. 1 is a schematic illustration of structural characteristics of an apparatus of the present invention
  • Figs. 2A-2C schematically illustrate examples of mouth-piece applicator embodiments of the present invention for facial skin rejuvenation
  • Fig. 3 is an example of a power source and control unit for use with the mouthpiece applicator.
  • Figs. 4A-4D depict AC waveforms that may be used for generation of the RF current.
  • FIG. 1 showing a schematic block diagram of An apparatus 10 (medical or cosmetic) configured in accordance with the present invention.
  • the apparatus 10 includes an applicator 100, and an electromagnetic (RF) power source and control device 400.
  • the applicator 100 and the power source and control device 400 are configured for connection between them, generally designated 200, which may refer to a direct electric connector 200 or a signal transmission 200.
  • the power source and control device 400 may be integrated with the applicator 100, being a constructional part of the applicator 100, and being operable either using a battery or connection to a power network.
  • the power source and control device 400 may be placed in a separate package/enclosure 20.
  • the elements of the power source and control device 400 may be distributed between the applicator unit 100 and separate package/enclosure 20.
  • the applicator 100 includes an electrode assembly 120, configured to be in electric communication with the power source and control unit 400, via the connection 200.
  • the electrode assembly 120 when operated (supplied with electrical signal), creates one or more of RF current/energy regions (generally at 101) in the treated facial internal tissue.
  • the power source and control unit 400 includes a control unit 444, and a power generator 430 which is connected to and activated by the control unit 444 via a connection circuit 452, which may be a wired or wireless connection.
  • the power generator 430 and the control unit 444 may be joined together in a common package/enclosure 20, or may be placed in two separate packages/enclosures 22 and 24.
  • one of the power generator 430 and the control unit 444 may be integrated with the applicator 100, while the other of them is left in its separate package.
  • the power generator 430 is integral with the electric applicator
  • the control unit 444 is a separate unit which controllably modifies the electric signal generated by the power generator 430 by a predetermined activation function and possibly its settings are updated for a specific individual (via user interface) 450.
  • the parameter can be related to tissue characteristics such as temperature, conductivity, reflectivity, impedance and any combination thereof.
  • the feedback control may be based on at least one of the following: the measurement, the change in measurement as a function of time, the difference between a measurement for one tissue portion and the measurement for another tissue portion, the difference between change in measurement for one tissue portion and the change in measurement for another tissue portion and any combination thereof.
  • the control unit 444 alters the at least one parameter of the treatment in order to accomplish the desired rejuvenation treatment.
  • the control unit 444 can discontinue treatment for that tissue portion, while continuing treatment to other tissue portion(s) which have not yet arrived at the desired heating/temperature effect.
  • the treatment parameters can be adjusted for that tissue portion, for example by increasing the RF current intensity or duration to that tissue portion.
  • the power source and control unit 400 is responsible for generating the RF signals which are then transmitted (via the operation of the control unit to provide a desired profile of said signals) to the electrode assembly 120 in the applicator 100.
  • the power source and control unit 400 includes the power generator 430 which physically generates the RF signals modified by the activation function produced by the control unit 444.
  • the control unit 444 is typically a computerized system being hardware and/or software based system, and includes at least such as modules as a field profiling module 446, a duration controlling module 448 for controlling duration of a treatment session, and a user interface module 450.
  • the control unit 444 also includes a formulation/gel/substance controller 451, configured for measuring or monitoring one or more parameters of the formulation/substance (material status), which may be indicative of the treatment process, such as for example measurement of impedance of the formulation/substance.
  • the substance controller is actually associated with a measurement / sensing circuit (electric, optical, electro-optical, etc.), which is typically integral with the applicator 100 and connectable (via wires or wireless) to the formulation controller 451.
  • the control unit may also include a process controller 453 for controlling various parameters and conditions of the rejuvenation treatment process, such as one of the following: control the amount and location of the formulation.
  • the power source and control unit 400 may include one or more indicators which is/are associated with one or more sensor(s) and controller(s) to provide indication and alert the user if the treatment process deviates from the treatment plan / program.
  • the field profiling module 446 generates a control function (shown at 201) which is a time and frequency function and controls the profile / shape (the frequency and amplitude over time) of the electric/magnetic RF field/signals to form a desired RF activation function 202.
  • the control function (shown at 201) may be applied to the output of the power generator 430 (or may be fed into the power generator) in order to properly modify the electric/magnetic RF field activating signal.
  • the power generator can be supplied with a power inlet for connecting to a direct current (DC) outlet or a power inlet for connecting to an AC outlet.
  • the power generator or the control unit can include an AC-DC converter and/or a DC-AC converter (as well as A-to-D converter). If the power generator includes a battery, then either the power generator or the control unit includes an appropriate DC-AC converter.
  • the parameters of the control function and accordingly of the activation function may be of any suitable shape or magnitude.
  • the shape of the activation function may be one or a combination of sinusoidal, rectangular, triangular, saw tooth or any other suitable shape.
  • the frequency of the RF electrical signal is relatively high, e.g.
  • the treatment protocol may include application of a generated RF signal which has a single shape and a single frequency for the whole duration of activation, or it may have a consequence of shapes and frequencies.
  • the treatment session may include several activation functions applied to several electrodes in order to activate several localized treatment protocols to selected tissue portions in the region being treated.
  • the control unit 444 also controls the duration of the treatment session via the module 448, and possibly also a time pattern of multiple treatment sessions, which may be similar or different in the duration times and/or activation functions produced by the module 446.
  • the applicator 100 includes a treatment surface 102 and a formulation/substance chamber 106.
  • the treatment surface/interface 102 is configured to be placed on the intraoral tissue undergoing treatment.
  • the electrode assembly is mounted on the treatment surface/interface 102 and preferably touches the tissue.
  • the formulation/substance used with the treatment procedure (such as Hyaluronic Acid) is placed in the chamber 106 such that the formulation is located between the treatment surface 102, including the electrode assembly 120, and the treated tissue.
  • the treatment surface 102 can include one continuous treatment site or a plurality of spaced-apart treatment sites 104 defined and configured to contact the formulation, such that the treatment site(s) define respective electrode-formulation-tissue contact region(s) located inside the RF energy region 101 thereby defining treatment zone(s) where treatment is applied, in the case, more than one treatment site exists, the applicator 100 may include one chamber 106 being in contact with the plurality of treatment sites, or a corresponding plurality of respective chamber(s) 106.
  • the formulation chamber(s) 106 is/are configured as compartment(s) configured to receive the formulation (substance, gel) therein.
  • the applicator 100 is configured to hold the formulation embedded in a specially designed grooves or pockets which are configured to controllably release the formulation into the chamber(s) to be in contact with the electrode assembly 120 and the tissue when required.
  • the electrode assembly 120 of the applicator 100 may include at least one electrode working in a monopolar mode (such that the subject's body may serve as the counter electrode), or may include at least one pair of electrodes working for example in bipolar mode.
  • the electrode assembly can include a plurality of electrodes (an array of electrodes, a matrix of fractionated electrodes) configured to create a plurality (one- two- or three-dimensional array) of RF current regions defining the different treatment sites 104.
  • the parameters/conditions in the multiple RF current regions are preferably separately controlled/operated by separately operating and controlling each or a group of electrodes in the electrode array.
  • Such electrode assembly when operated, creates multiple RF regions associated with respective multiple treatment sites.
  • the electrode(s) of the electrode assembly is/are preferably made of a biocompatible conductive material such as, but not limited to, stainless steel, titanium, gold and any combination thereof.
  • the electrodes are preferably individually controllable via the control unit 444.
  • the electrodes can have either same or different currents, voltages, waveforms, frequencies, duty cycles, treatment times, and any combination thereof.
  • the apparatus 10 of the present invention provides full control over all the parameters needed to execute a successful and effective tissue rejuvenation treatment.
  • the full or partial control of the treatment process parameters may be setup in the control unit 444 prior to supplying the apparatus, or only the control unit, to the user, and/or may give the user access for updating / adjusting the parameter(s).
  • the apparatus 10 may be supplied in a specific kit for use in tissue rejuvenation treatment (professional or home use).
  • the kit includes a set of one or more applicators, one or more power source and control units, and one or more formulation (such as Hyaluronic Acid) packages.
  • the mouth-piece applicator 100A includes a housing 110A including the treatment surface 102A, an electrode assembly 120A and a formulation chamber 106A.
  • the housing 110A is configured to be positioned inside the subject's mouth such that it contacts or attaches to the internal facial tissue undergoing treatment.
  • the housing 110A is configured to be inserted into the subject's mouth such that it surrounds the teeth on their outer side, by its internal side llOi, and is pushed against the internal side of the face (the oral mucosa), by its external side llOe which is the treatment surface.
  • the housing 110A has a U-like shape, such that the bottom side of the U-like shape surrounds the frontal teeth when the applicator is located inside the mouth.
  • the housing is configured as a two U-like upper and lower portions configured to surround the upper and lower teeth arcades and to contact the upper and lower parts of the facial internal tissue respectively.
  • the housing may be configured as a right or left half U- like shape configured to be applied to one side of the face.
  • the housing shape can be custom-made to fit the shape of the specific facial internal tissue portion to which the RF energy is going to be applied. Additionally or alternatively, the control over the tissue portion undergoing treatment can be achieved through the activation of a specific part of the electrode assembly as will be detailed below, while using a unified U- like housing.
  • the housing 110A is made from a biocompatible, nonconductive material, such as , but not limited to, silicon , a foam material, nylon, or PVC; and any combination thereof.
  • the housing is configured to attach or conform to the treated tissue by pushing against the internal facial tissue, either by adjusting its size such that it fits tightly, yet comfortably, between the teeth and the facial internal tissue, or by providing it with a structure that pushes the U arms outwardly such that they attach and stick to the facial internal tissue even if they do not come in contact with the teeth.
  • the latter can be achieved by a spring in compression located between the U arms which naturally causes the U arms to move outwardly via the spring' s relaxation.
  • the spring' s stiffness is defined in view of the desired pushing force applied against the facial internal tissue.
  • the electrode assembly includes a single electrode 120A extending along the perimeter/envelope of the housing 110A, to thereby enable treating the whole facial tissue; therefore, a single, monopolar, treatment is applied to the whole treated tissue each time.
  • the electrode assembly is mounted on the external side llOe , being fully exposed, such that it contacts the oral mucosa, when the applicator is inserted in the subject's mouth.
  • the formulation chamber 106A is in the form of a groove located on the external side llOe and extends along the perimeter of the U-like housing 110A, substantially parallel to the electrode assembly, for receiving the formulation and enabling the electrode-formulation-tissue contact and defining the treatment zone.
  • Fig. 2B other possible variations of the electrode assembly and the applicator housing are shown. Again, it is noted that all the presented variations can be mixed and matched.
  • the configuration of the housing can be used with the single electrode 120A described above in Fig. 2A.
  • the applicator 100B has a housing HOB of a U-like shape, similar to the applicator 100A, however, the electrode assembly 120B is partially exposed on the outer side of the housing HOB, such that the housing has openings or channels 112B along its perimeter configured to insert the electrode assembly 120B therethrough. This is particularly helpful when building the housing from a flexible material, such as silicon, because this helps in fixating the electrode assembly on the housing.
  • the electrode assembly 120B includes two electrodes 120B1 and 120B2, arranged one above the other, with a predefined distance therebetween. This configuration enables at least two different activation modes depending on how they are connected to the power source and control unit 400.
  • the first activation mode is by activating the two electrodes in bi-polar mode, such that the RF current flows from one electrode through the facial tissue and the formulation (if used) to the second electrode. This enables a single treatment to the whole contacted tissue each time.
  • the second activation mode is by activating each of the two electrodes separately in monopolar mode, and in this case two separate treatments can be applied to two different tissue portions (practically, the upper part of the face and the lower part of the face), or if needed the treatment is applied only to one tissue portion by activating only one of the electrodes.
  • the formulation chamber 106B includes two chambers 106B1 and 106B2, each aligned with one of the two electrodes to enable maximum activation flexibility, e.g. when activating only one electrode, there is no need to use the chamber aligned with the second electrode.
  • the applicator lOOC has a housing HOC having a dental tray form, such as those used by dentists to take samples of the teeth arcades. This structure can enable easy installation of the applicator inside the mouth and secure fit and positioning.
  • the applicator can also comprise a thermistor which monitors the temperature during the heating process.
  • the thermistor can be embedded in the applicator, attached to the surface of the applicator, or can stand proud of the applicator.
  • the temperature in the oral cavity can be kept in a range between about 39 degrees C and about 48 degrees C. It should be noted that the term 'about' used herein typically refers to a range of plus or minus 25% around the nominal value.
  • the applicator comprises sensors, such as, but not limited to a thermistor, an ammeter, a voltage meter, an optical sensor and any combination thereof.
  • FIG. 3 showing a schematic illustration of an example of the apparatus 10 of the present invention.
  • a power source and control unit 400A located in a separate enclosure 20A, and the applicator 100A are connected together with the help of a wired connection 200A.
  • a control unit 444A (hardware/software), installed in the power source and control unit 400A, includes a user interface 450A including external controls 500A which enable a user to set treatment parameters including, but not limited to, treatment time, magnitude of the current, type of AC waveform, maximum and minimum temperatures in the mouth cavity during treatment, maximum and minimum temperatures in the treated tissue during treatment, magnitude of the voltage, AC frequency, and any combination thereof.
  • the control unit can also include one or more display means 600A to display parameters such as, but not limited to, time left in a treatment, time elapsed since the start of the treatment, temperature in the oral cavity, magnitude of the current, magnitude of the voltage, selected waveform, measured waveform, and any combination thereof.
  • the display 600A can be, for non-limiting example, a screen showing text and/or graphics, lights of different colors or in different positions, a bell, buzzer or other producer of sound, and any combination thereof.
  • the screen or a button could show one color if the treatment is proceeding normally, a second color if the temperature in the oral cavity or oral mucosa is too low, a third color if the temperature is approaching the upper limit, and a fourth color if the temperature is too high.
  • the control unit may also generate audible warnings sounds, e.g. when a treatment is completed, or when a predetermined amount of time is left before completion of a treatment (e.g., a warning one minute before a treatment is completed).
  • an audible warning is sounded after a predetermined period of time elapses during a treatment (e.g., a beep once a minute during a ten-minute treatment). Any combination of warnings can be made. Warnings can be the same, or they can be different.
  • the frequency of the current can be defined by the control unit in the range from about 300.0 KHz to about 40.0MHz. Typically, it is in a range either from about 1.0 MHz to about 10.0 MHz or from about 1.0MHz to about 8.0MHz.
  • the RMS amplitude of the current can be in the range from about 0.005 amp to about 1.0 amp.
  • the RMS power can be in the range from about 0.005W to about 50.0W.
  • the current and voltage can be applied continuously or they can be pulsed.
  • a pulsed application alternately, AC current and voltage are applied for a time substantially longer than the time for one waveform, and no current or voltage is applied for a time substantially longer than the time for one waveform.
  • a pulsed treatment could comprise a treatment time of 10 min, with the AC current being on for 2 s and off for 4 s, for a total of 100 pulses during the treatment.
  • the duty cycle of a pulsed application the ratio of the fraction of the time that current is applied to the fraction of the time that no current is applied, can be between 0 and 100%. A 100% duty cycle is, of course, continuous treatment.
  • the control unit has separate controls for setting treatment time and activating the treatment current. In other embodiments, setting the treatment time to a non-zero value starts the treatment current.
  • the apparatus is configured to control the amount and location of the formulation within the formulation chamber and alerts the user if the amount of the formulation is not sufficient.
  • the apparatus e.g. the control unit 444
  • the apparatus can include a memory for building a database and storing physical parameters of the formulation such as, but not limited to impedance, density, heat capacity, current through the compound for a predetermined voltage, and any combination thereof and preferred or optimal treatment parameters such as, but not limited to, treatment time, treatment temperature, treatment temperature change, duty cycle, waveform, AC frequency and any combination thereof.
  • the waveform can be a sine wave (Fig. 4A), a square wave (Fig. 4B), a triangular wave (Fig. 4C), a saw-tooth wave (Fig. 4D), and any combination thereof.
  • a non-limiting example of a treatment using the apparatus of the invention includes the following steps: (a) setting the parameters of a treatment; (b) optionally, filling an applicator with a formulation; (c) placing the applicator in the mouth; (d) closing the mouth so as to retain the applicator stably in position; (e) starting the treatment by activating the power generator source (f) waiting until the treatment is complete, e.g. by achieving a predetermined required temperature in the deep layers of the facial tissue; and (g) removing the applicator from the mouth.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgical Instruments (AREA)

Abstract

L'invention concerne un appareil et un procédé pour le rajeunissement du tissu cutané facial. L'appareil comprend un applicateur d'embout buccal introduit dans la bouche pour appliquer une énergie RF à une partie de muqueuse buccale située à l'opposé d'une partie du tissu cutané facial, l'applicateur comprenant un boîtier comprenant une surface de traitement destinée à être positionnée à proximité de la partie de la muqueuse buccale ; et un ensemble électrode monté sur la surface de traitement de telle sorte que l'ensemble électrode fait face à la partie de la muqueuse buccale, l'ensemble électrode délivre un courant RF d'un profil prédéterminé à la partie de la muqueuse buccale, ce qui permet de chauffer des couches de tissu profond sous la partie de la muqueuse buccale à un profil de température prédéterminé ; et une unité de commande et de source d'alimentation conçue pour générer au moins un signal d'activation présentant un profil temps-fréquence prédéterminé pour faire fonctionner de manière régulée l'ensemble électrode pour créer ledit profil prédéterminé de courant RF et générer ledit profil de température prédéterminé.
PCT/IL2018/050019 2017-01-09 2018-01-07 Appareil et procédé pour le rajeunissement de la peau WO2018127921A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762443993P 2017-01-09 2017-01-09
US62/443,993 2017-01-09

Publications (1)

Publication Number Publication Date
WO2018127921A1 true WO2018127921A1 (fr) 2018-07-12

Family

ID=62790791

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2018/050019 WO2018127921A1 (fr) 2017-01-09 2018-01-07 Appareil et procédé pour le rajeunissement de la peau

Country Status (1)

Country Link
WO (1) WO2018127921A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114344708A (zh) * 2021-12-31 2022-04-15 广州星际悦动股份有限公司 口内美容仪
US20220395087A1 (en) * 2019-11-11 2022-12-15 Proxihealthcare Inc. Toothbrush for promoting plaque removal and manufacturing method therefor
WO2025100880A1 (fr) * 2023-11-07 2025-05-15 에스에스비상사 주식회사 Dispositif de mise à la terre buccal optimisé pour des affections buccales

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5490520A (en) * 1993-09-27 1996-02-13 Schaefer Partnership Dental applicance for treating bruxism
US20140093832A1 (en) * 2007-09-05 2014-04-03 Biolectrics Llc Concurrent Treatment of Oral and Systemic Maladies in Animals Using Electrical Current
US20160228177A1 (en) * 2013-09-09 2016-08-11 Syneron Medical Ltd. A system for periodontal treatment
WO2016151570A1 (fr) * 2015-03-25 2016-09-29 Brighttonix Medical Ltd. Système et procédé de blanchiment de tissu par application de champ électromagnétique
US20160346561A1 (en) * 2008-06-29 2016-12-01 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5490520A (en) * 1993-09-27 1996-02-13 Schaefer Partnership Dental applicance for treating bruxism
US20140093832A1 (en) * 2007-09-05 2014-04-03 Biolectrics Llc Concurrent Treatment of Oral and Systemic Maladies in Animals Using Electrical Current
US20160346561A1 (en) * 2008-06-29 2016-12-01 Venus Concept Ltd. Esthetic apparatus useful for increasing skin rejuvenation and methods thereof
US20160228177A1 (en) * 2013-09-09 2016-08-11 Syneron Medical Ltd. A system for periodontal treatment
WO2016151570A1 (fr) * 2015-03-25 2016-09-29 Brighttonix Medical Ltd. Système et procédé de blanchiment de tissu par application de champ électromagnétique

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220395087A1 (en) * 2019-11-11 2022-12-15 Proxihealthcare Inc. Toothbrush for promoting plaque removal and manufacturing method therefor
CN114344708A (zh) * 2021-12-31 2022-04-15 广州星际悦动股份有限公司 口内美容仪
WO2025100880A1 (fr) * 2023-11-07 2025-05-15 에스에스비상사 주식회사 Dispositif de mise à la terre buccal optimisé pour des affections buccales

Similar Documents

Publication Publication Date Title
AU2021269187B2 (en) Device and method for unattended treatment of a patient
EP2307095B1 (fr) Appareil esthétique utile pour accentuer le rajeunissement de la peau
JP6768788B2 (ja) フェイスリフト機
KR101805683B1 (ko) 플라즈마 및 근적외선을 이용한 피부 미용 장치
WO2023281448A1 (fr) Appareil à usage esthétique utile pour accroître le rajeunissement de la peau et méthodes associées
JP2010535595A (ja) 多重モジュール皮膚または身体治療システムおよびその使用法
KR101472983B1 (ko) 고주파 온열 치료 장치
KR20190099371A (ko) 피부 미용 및 치료 시스템
WO2018127921A1 (fr) Appareil et procédé pour le rajeunissement de la peau
CN219208739U (zh) 用于对患者进行无人照管的治疗的装置
WO2018080601A1 (fr) Dispositif et procédé de réduction de la graisse mettant en œuvre des émetteurs optiques
WO2016151570A1 (fr) Système et procédé de blanchiment de tissu par application de champ électromagnétique
KR102614001B1 (ko) 피부 미용 장치 및 이를 이용한 피부 미용 방법
WO2023078896A1 (fr) Dispositif et procédé pour le traitement automatisé d'un patient
AU2023203099B2 (en) Device and method for unattended treatment of a patient
US20190217119A1 (en) Interchangeable modular cap for laser light therapy
AU2022100167A4 (en) Device and method for unattended treatment of a patient
EA044406B1 (ru) Устройство и способ для полностью автоматического лечения пациента
TW201832795A (zh) 可置換式光電療盒
EP3531947A1 (fr) Dispositif et procédé de réduction de la graisse mettant en oeuvre des émetteurs optiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18736562

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18736562

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载